Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years.
暂无分享,去创建一个
M Rovaris | M Filippi | B Benedetti | G. Comi | M. Rovaris | M. Filippi | M. Sormani | V. Martinelli | A. Ghezzi | R. Bergamaschi | A. Gallo | B. Benedetti | G. Mancardi | D. Caputo | E. Judica | E. Montanari | A. Bertolotto | G Comi | D Caputo | A Bertolotto | M P Sormani | A Ghezzi | R Bergamaschi | V Martinelli | E Judica | A Gallo | E Montanari | G Mancardi
[1] A. Thompson,et al. Primary progressive multiple sclerosis: a 5-year clinical and MR study. , 2003, Brain : a journal of neurology.
[2] Alan J. Thompson,et al. Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis , 2004, NeuroImage.
[3] Marco Rovaris,et al. Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study. , 2002, Archives of neurology.
[4] A J Thompson,et al. Clinical and Magnetic Resonance Imaging Predictors of Disability in Primary and Secondary Progressive Multiple Sclerosis , 1996, Multiple sclerosis.
[5] P M Matthews,et al. Evidence for widespread movement-associated functional MRI changes in patients with PPMS , 2002, Neurology.
[6] A. Thompson,et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. , 1996, Brain : a journal of neurology.
[7] F. Barkhof,et al. The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study , 2002, Multiple sclerosis.
[8] F. Barkhof,et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. , 1998, Brain : a journal of neurology.
[9] F. Barkhof,et al. Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.
[10] P. Matthews,et al. Normalized Accurate Measurement of Longitudinal Brain Change , 2001, Journal of computer assisted tomography.
[11] G. Barker,et al. MRI dynamics of brain and spinal cord in progressive multiple sclerosis. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[12] A. Thompson,et al. One year follow up study of primary and transitional progressive multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.
[13] O. Ciccarelli,et al. Diffusion MRI in multiple sclerosis , 2005, Neurology.
[14] F. Barkhof,et al. Long-term clinical outcome of primary progressive MS: Predictive value of clinical and MRI data , 2005, Neurology.
[15] M. Rovaris,et al. Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis. , 2005, Archives of neurology.
[16] A J Thompson,et al. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. , 2005, Archives of neurology.
[17] Christian M Kerskens,et al. Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study , 2004, Multiple sclerosis.
[18] A J Thompson,et al. A comparison of the pathology of primary and secondary progressive multiple sclerosis. , 1994, Brain : a journal of neurology.
[19] R. Ordidge,et al. High field MRI correlates of myelin content and axonal density in multiple sclerosis , 2003, Journal of Neurology.
[20] Hans Lassmann,et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.
[21] P. Matthews,et al. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. , 2000, Brain : a journal of neurology.
[22] A J Thompson,et al. Diagnostic criteria for primary progressive multiple sclerosis: A position paper , 2000, Annals of neurology.
[23] J. Winn,et al. Brain , 1878, The Lancet.
[24] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[25] D. Chard,et al. Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial. , 2003, Neurology.
[26] A. Thompson,et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis , 1991, Annals of neurology.
[27] A. Thompson,et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[28] A. Thompson,et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. , 1990, BMJ.
[29] Marco Rovaris,et al. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. , 2003, Brain : a journal of neurology.
[30] D. Miller,et al. Interferon β-1a in primary progressive MS , 2003, Neurology.
[31] G. Comi,et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. , 2001, Brain : a journal of neurology.
[32] M. Filippi,et al. Correlations between Structural CNS Damage and Functional MRI Changes in Primary Progressive MS , 2002, NeuroImage.
[33] M Cercignani,et al. Diffusion tensor magnetic resonance imaging in multiple sclerosis , 2001, Neurology.
[34] F. Barkhof,et al. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. , 2001, Archives of neurology.
[35] Stephen M. Smith,et al. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.
[36] A. Thompson,et al. A longitudinal study of cognition in primary progressive multiple sclerosis. , 2005, Brain : a journal of neurology.
[37] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[38] J. Baskerville,et al. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.
[39] Massimo Filippi,et al. Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. , 2002, AJNR. American journal of neuroradiology.
[40] Marco Rovaris,et al. Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI , 2005, NeuroImage.
[41] Zografos Caramanos,et al. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis , 2002, Journal of Neurology.
[42] J. Baskerville,et al. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. , 1991, Brain : a journal of neurology.
[43] F. Barkhof,et al. Primary and transitional progressive MS , 1999, Neurology.
[44] Mara Cercignani,et al. Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. , 2005, Brain : a journal of neurology.
[45] A. Thompson,et al. Magnetic resonance imaging predictors of disability in primary progressive multiple sclerosis: a 5-year study , 2004, Multiple sclerosis.
[46] A. J. Thompson,et al. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis , 2003, Journal of Neurology.
[47] M Rovaris,et al. Two-year follow-up study of primary and transitional progressive multiple sclerosis , 2002, Multiple sclerosis.
[48] B. Trapp,et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.
[49] A J Thompson,et al. Is inflammation important in early PPMS? a longitudinal MRI study , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[50] J. Dehmeshki,et al. The normal appearing grey matter in primary progressive multiple sclerosis , 2003, Journal of Neurology.
[51] Frederik Barkhof,et al. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. , 2005, AJNR. American journal of neuroradiology.